SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹63 Cr | ₹0.58 Cr | ₹-2.45 Cr | ₹0.83 Cr | ₹-1.08 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹63 Cr |
Mar2023 | ₹0.58 Cr |
Mar2022 | ₹-2.45 Cr |
Mar2017 | ₹0.83 Cr |
Mar2016 | ₹-1.08 Cr |
How is Net Cash Inflow / Outflow of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹63 Cr | 10,713.84 | |
Mar2023 | ₹0.58 Cr | Positive | |
Mar2022 | ₹-2.45 Cr | Negative | |
Mar2017 | ₹0.83 Cr | Positive | |
Mar2016 | ₹-1.08 Cr | - |
Compare Net Cash Inflow / Outflow of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,051.1 Cr | -7.6% | 2.9% | 87.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹435,179.0 Cr | 0.4% | 0.8% | 45.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,995.0 Cr | -1.4% | 1.2% | 62% | Stock Analytics | |
CIPLA | ₹116,890.0 Cr | -1.5% | -5.1% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,993.0 Cr | -0.7% | -1.3% | 13.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,444.9 Cr | -0.5% | 3% | 54.1% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -7.6% |
2.9% |
87.4% |
SENSEX | 0.5% |
3.3% |
17.6% |
You may also like the below Video Courses